Cell and Gene Therapy Clinical Trials 2025 Edition
Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier…
AAD 2025 Preview: Key Dermatology Highlights to Watch
AAD 2025 at a glance With AAD 2025 on the horizon, here’s a preview of…
AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch
AAAAI 2025 at a glance As AAAAI 2025 approaches, LucidQuest highlights…
ESGO 2025 Preview: Highlights in Gynecologic Oncology to Watch
ESGO 2025 at a Glance Get ready for ESGO 2025 in Rome. LucidQuest…
ECCO 2025 Preview: Key Crohn’s and Colitis Highlights to Watch
ECCO 2025 at a glance As ECCO 2025 approaches, LucidQuest summarizes the…
IMCAS 2025 Preview: Key Aesthetic Medicine Highlights to Watch
IMCAS 2025 at a glance Prepare for IMCAS 2025 with LucidQuest’s preview,…
AI-Powered Medical Affairs: Enhancing value, engagement, and insights
The pharmaceutical sector is witnessing a transformative shift fueled by the…
Unveiling the Financial Ties: HCPs, PAOs and Pharmaceutical Funding
The entanglement of financial relationships among healthcare professionals…
New antibiotics on the way: How pharma can tackle the Antimicrobial Resistance crisis
The overuse and misuse of antimicrobials in humans and animals have escalated…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
The Next Frontier: Pharma and Longevity
From The Epic of Gilgamesh, the earliest surviving book, to the controversial…
